About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep increases the risk of severe asthma exacerbations (attacks) that often ...

Asthma isn't just about your lungs. Discover the hidden emotional loop that can worsen symptoms and how to manage the cycle.

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in adolescents with overweight or obesity, according to a research letter ...

Severe asthma affects roughly 2 million people in the United States. It is hard to control — even with inhaled steroid medicines and additional therapies. More than 80% of cases are linked to type 2 ...

Children's Wisconsin reported seeing 11 critical asthma cases in children at its ER and urgent care clinics, an unusually ...

We often mistake a lingering cough as a stubborn cold or a seasonal allergy. However, medical experts warn that such subtle, ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use has recommended the granting of a marketing authorization for Exdensur (depemokimab, GlaxoSmithKline) for severe ...

Please provide your email address to receive an email when new articles are posted on . 23.7% of patients with asthma were classified with severe persistent asthma. 40.9% of patients with severe ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...